Recurrent indolent non-Hodgkin lymphoma
Clinical trials for Recurrent indolent non-Hodgkin lymphoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent indolent non-Hodgkin lymphoma trials appear
Sign up with your email to follow new studies for Recurrent indolent non-Hodgkin lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Target CAR T-Cells offer new hope for tough blood cancers
Disease control Recruiting nowThis early-stage trial tests a new type of cell therapy for people with certain blood cancers (like lymphoma, leukemia) that have returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, which are genetically modified to recognize and …
Matched conditions: RECURRENT INDOLENT NON-HODGKIN LYMPHOMA
Phase 1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could fewer zaps do the job? new trial tests low-dose radiation for lymphoma
Disease control Recruiting nowThis study compares a reduced radiation dose (3 treatments) against the standard 12 treatments for people with indolent (slow-growing) non-Hodgkin lymphoma. The goal is to see if the shorter course is safer and still works well at controlling the cancer. About 112 adults with cer…
Matched conditions: RECURRENT INDOLENT NON-HODGKIN LYMPHOMA
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC